SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Amendment No. ) *
Information to be included in statements filed pursuant to Rules 13d-1(b), (c) and (d) and
amendments thereto filed pursuant to Rule 13d-2(b)
Regado Biosciences, Inc.
(Name of Issuer)
Common Stock, par value $0.001 per share
(Title of Class of Securities)
75874Q107
(CUSIP Number)
August 27, 2013
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
| ¨ | Rule 13d-1(b) |
| x | Rule 13d-1(c) |
| ¨ | Rule 13d-1(d) |
| * | The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. |
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
| CUSIP No. 75874Q107 |
| 1. | Names of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only).
Robert A. Kierlin | |||||
| 2. | Check the Appropriate Box if a Member of a Group (See Instructions) (a) ¨ (b) ¨
NOT APPLICABLE | |||||
| 3. | SEC Use Only
| |||||
| 4. | Citizenship or Place of Organization:
United States | |||||
Number of Shares Beneficially Owned by Each Reporting Person With | 5. | Sole Voting Power:
3,309,955 | ||||
| 6. | Shared Voting Power:
None | |||||
| 7. | Sole Dispositive Power:
3,309,955 | |||||
| 8. | Shared Dispositive Power:
None | |||||
| 9. | Aggregate Amount Beneficially Owned by Each Reporting Person:
3,309,955 | |||||
| 10. | Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
NOT APPLICABLE | |||||
| 11. | Percent of Class Represented by Amount in Row (9):
16.2% | |||||
| 12. | Type of Reporting Person –
IN | |||||
Page 2
| CUSIP No. 75874Q107 |
Item 1.
| (a) | Name of Issuer: Regado Biosciences, Inc. |
| (b) | Address of Issuer’s Principal Executive Offices: |
120 Mountain View Boulevard
Basking Ridge, New Jersey 07920
Item 2.
| (a) | Name of Person Filing: |
Robert A. Kierlin
| (b) | Address of Principal Business Office or, if none, Residence: |
Robert A. Kierlin
Fastenal Company
2001 Theurer Boulevard
Winona, Minnesota 55987-1500
| (c) | Citizenship: |
Robert A. Kierlin is a citizen of the United States.
| (d) | Title of Class of Securities: |
Common Stock, par value $0.001 per share
| (e) | CUSIP Number: 75874Q107 |
Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
NOT APPLICABLE
Page 3
| CUSIP No. 75874Q107 |
Item 4. Ownership
| (a) | Amount Beneficially Owned: | 3,309,955 | ||
| (b) | Percent of Class: | 16.2% | ||
| (c) | Number of Shares as to which such person has: | |||
| (i) | sole power to vote or to direct the vote: | 3,309,955 | ||||
| (ii) | shared power to vote or to direct the vote: | 0 | ||||
| (iii) | sole power to dispose or to direct the disposition of: | 3,309,955 | ||||
| (iv) | shared power to dispose or to direct the disposition of: | 0 | ||||
Item 5. Ownership of Five Percent or Less of a Class
NOT APPLICABLE.
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
NOT APPLICABLE
Page 4
| CUSIP No. 75874Q107 |
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
NOT APPLICABLE
Item 8. Identification and Classification of Members of the Group
NOT APPLICABLE
Item 9. Notice of Dissolution of Group
NOT APPLICABLE
Item 10. Certification
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.
Page 5
| CUSIP No. 75874Q107 |
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
| September 3, 2013 |
| /s/ Robert A. Kierlin |
Robert A. Kierlin |
Attention: Intentional misstatements or omissions of fact constitute
Federal criminal violations (See 18 U.S.C. 1001)
Page 6
